ReNerve Limited (ASX:RNV)
0.0700
0.00 (0.00%)
Nov 20, 2026, 9:59 AM AEDT
ReNerve Market Cap
ReNerve has a market cap or net worth of 12.06 million as of November 19, 2026. It is the 42,368th most valuable company in the world and the 1,220th biggest in Australia. Its market cap has decreased by 45.92% in one year.
Market Cap
12.06M
Enterprise Value
10.77M
Revenue
510.36K
Global Rank
Country Rank
#1,220 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since November 26, 2024, ReNerve's market cap has decreased from 26.95M to 12.06M, a decrease of -55.25%. That is a compound annual growth rate of -33.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2026 | 12.06M | -27.11% |
| Dec 31, 2025 | 16.55M | -33.34% |
| Dec 31, 2024 | 24.82M | -7.89% |
| Nov 26, 2024 | 26.95M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Miro Sciences | 16.76M |
| Proteomics International Laboratories | 15.55M |
| Imugene | 15.18M |
| Ceryvyn Therapeutics | 15.05M |
| EZZ Life Science Holdings | 13.65M |
| Radiopharm Theranostics | 13.01M |
| Patrys | 12.81M |
| Noxopharm | 12.03M |